United Laboratories International Holdings (FRA:UNJ) Moat Score: 5/10 (As of Jul. 16, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:UNJ United Laboratories International Holdings Ltd FRA:UNJ
85 GF Score
Price €1.00
GF Value €0.96
! 5 Warning Signs
View Full Analysis

What is United Laboratories International Holdings Moat Score?

United Laboratories International Holdings FRA:UNJ +1.01% 85 Moat Score is 5 as of Jul. 16, 2026. GuruFocus rates FRA:UNJ with a GF Score™ of 85/100 and a GF Value™ of €0.96. The stock has 5 warning signs investors should review. Among 1,031 Drug Manufacturers companies, United Laboratories International Holdings ranks better than 94.67% on this metric.

United Laboratories International Holdings has the Moat Score of 5, which implies that the company might have Narrow Moat - Solid narrow moat.

United Laboratories International Holdings has Narrow Moat: United Laboratories International Holdings Ltd benefits from valuable intellectual property and some regulatory barriers in the pharmaceutical industry. However, it lacks strong brand strength and deep customer loyalty, resulting in a solid narrow moat.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes United Laboratories International Holdings might have Narrow Moat - Solid narrow moat.

United Laboratories International Holdings  (FRA:UNJ) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

United Laboratories International Holdings Moat Score Related Terms

FRA:UNJ vs ZTS, UTHR: Moat Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, United Laboratories International Holdings's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

United Laboratories International Holdings Moat Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, United Laboratories International Holdings's Moat Score distribution charts can be found below:

* The bar in red indicates where United Laboratories International Holdings's Moat Score falls into.


FRA:UNJ
85GF Score
United Laboratories International Holdings Ltd FRA:UNJ
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 5 mean?
United Laboratories International Holdings (FRA:UNJ) has a Moat Score of 5 as of Jul. 16, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, United Laboratories International Holdings ranks #55 out of 1031 companies in the Drug Manufacturers industry, placing it in the top 5.3%.
Is United Laboratories International Holdings' Moat Score too high?
United Laboratories International Holdings' current Moat Score is 5. Based on the distribution chart, United Laboratories International Holdings ranks #55 out of 1031 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, United Laboratories International Holdings has a GF Score™ of 85/100, reflecting its overall financial health beyond just this single metric.
How does United Laboratories International Holdings' Moat Score compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, United Laboratories International Holdings ranks #55 out of 1031 companies for Moat Score. This places United Laboratories International Holdings in the top 5% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Drug Manufacturers company?
A good Moat Score depends on the Drug Manufacturers industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. United Laboratories International Holdings's current Moat Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is United Laboratories International Holdings stock overvalued right now?
United Laboratories International Holdings (FRA:UNJ) has a current Moat Score of 5. The stock's GF Value™ is €0.96, compared to a current price of €1.00 — trading 4.2% above its estimated fair value. The current Moat Score is 5. United Laboratories International Holdings' overall GF Score™ is 85/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For United Laboratories International Holdings (FRA:UNJ), the current Moat Score is 5 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is United Laboratories International Holdings (FRA:UNJ) Overvalued in 2026?

Based on GuruFocus' analysis, United Laboratories International Holdings stock appears to be overvalued. The current stock price of €1.00 is trading 4.2% above its estimated GF Value™ of €0.96.

Key valuation signals for FRA:UNJ:

  • Moat Score: 5
  • GF Value™: €0.96 vs. price of €1.00 (4.2% above fair value)
  • GF Score™: 85/100 with 5 warning signs

No single metric tells the full story. See the FRA:UNJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

United Laboratories International Holdings Business Description

Address No. 6 Fuk Wang Street, Yuen Long Industrial Estate, New Territories, Hong Kong, HKG
United Laboratories International Holdings Ltd is mainly engaged in the research and development, production and sales of pharmaceuticals. The company operates in three segments: Intermediate products, Bulk medicine, and Finished products. The company's Finished products segment includes antibiotic products, insulin series products, and other medicines. The vast majority of the company's revenue is derived from its Finished products segment, followed by Bulk medicine. The majority of the company's sales are generated in China, followed by Europe, India and other countries.
85GF Score

Get the complete analysis for FRA:UNJ

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.00
Price
€0.96
GF Value